Annual Total Assets
$9.99 M
+$706.00 K+7.61%
December 31, 2023
Summary
- As of February 7, 2025, CANF annual total assets is $9.99 million, with the most recent change of +$706.00 thousand (+7.61%) on December 31, 2023.
- During the last 3 years, CANF annual total assets has risen by +$466.00 thousand (+4.89%).
- CANF annual total assets is now -50.68% below its all-time high of $20.25 million, reached on December 31, 2021.
Performance
CANF Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$5.92 M
-$4.07 M-40.71%
June 30, 2024
Summary
- As of February 7, 2025, CANF quarterly total assets is $5.92 million, with the most recent change of -$4.07 million (-40.71%) on June 30, 2024.
- Over the past year, CANF quarterly total assets has dropped by -$5.11 million (-46.32%).
- CANF quarterly total assets is now -70.76% below its all-time high of $20.25 million, reached on December 31, 2021.
Performance
CANF Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
CANF Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.6% | -46.3% |
| 3 y3 years | +4.9% | -38.8% |
| 5 y5 years | +25.6% | -56.7% |
CANF Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.7% | +7.6% | -70.8% | at low |
| 5 y | 5-year | -50.7% | +22.2% | -70.8% | at low |
| alltime | all time | -50.7% | +510.9% | -70.8% | +328.5% |
Can-Fite BioPharma Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $5.92 M(-40.7%) |
| Dec 2023 | $9.99 M(+7.6%) | $9.99 M(+8.9%) |
| Sep 2023 | - | $9.17 M(-16.9%) |
| Jun 2023 | - | $11.03 M(-18.2%) |
| Mar 2023 | - | $13.49 M(+45.3%) |
| Dec 2022 | $9.28 M(-54.2%) | $9.28 M(-26.9%) |
| Sep 2022 | - | $12.71 M(-13.8%) |
| Jun 2022 | - | $14.75 M(-17.4%) |
| Mar 2022 | - | $17.85 M(-11.9%) |
| Dec 2021 | $20.25 M(+112.7%) | $20.25 M(+38.3%) |
| Sep 2021 | - | $14.64 M(+51.2%) |
| Jun 2021 | - | $9.68 M(-24.0%) |
| Mar 2021 | - | $12.74 M(+33.8%) |
| Dec 2020 | $9.52 M(+16.5%) | $9.52 M(-28.5%) |
| Sep 2020 | - | $13.33 M(+4.1%) |
| Jun 2020 | - | $12.80 M(+56.6%) |
| Dec 2019 | $8.17 M(+2.8%) | - |
| Dec 2019 | - | $8.17 M(-30.4%) |
| Sep 2019 | - | $11.75 M(-14.0%) |
| Jun 2019 | - | $13.67 M(+82.5%) |
| Mar 2019 | - | $7.49 M(-5.8%) |
| Dec 2018 | $7.95 M(+4.4%) | - |
| Dec 2018 | - | $7.95 M(-26.5%) |
| Sep 2018 | - | $10.82 M(-1.4%) |
| Jun 2018 | - | $10.98 M(-12.0%) |
| Mar 2018 | - | $12.47 M(+63.8%) |
| Dec 2017 | $7.61 M | - |
| Dec 2017 | - | $7.61 M(-13.2%) |
| Sep 2017 | - | $8.77 M(-14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $10.29 M(-16.1%) |
| Mar 2017 | - | $12.26 M(+20.6%) |
| Dec 2016 | $10.17 M(-42.2%) | - |
| Dec 2016 | - | $10.17 M(-14.0%) |
| Sep 2016 | - | $11.82 M(-14.5%) |
| Jun 2016 | - | $13.82 M(-15.9%) |
| Mar 2016 | - | $16.43 M(-6.7%) |
| Dec 2015 | $17.60 M(+72.8%) | - |
| Dec 2015 | - | $17.60 M(+15.7%) |
| Sep 2015 | - | $15.21 M(+77.9%) |
| Jun 2015 | - | $8.55 M(-14.2%) |
| Mar 2015 | - | $9.97 M(-2.1%) |
| Dec 2014 | $10.19 M(+53.5%) | - |
| Dec 2014 | - | $10.19 M(+109.4%) |
| Sep 2014 | - | $4.87 M(-24.4%) |
| Jun 2014 | - | $6.43 M(-26.3%) |
| Mar 2014 | - | $8.73 M(+31.6%) |
| Dec 2013 | $6.63 M(+305.7%) | $6.63 M(+106.8%) |
| Sep 2013 | - | $3.21 M(-30.2%) |
| Jun 2013 | - | $4.60 M(-22.4%) |
| Mar 2013 | - | $5.92 M(+262.3%) |
| Dec 2012 | $1.64 M(-66.6%) | - |
| Dec 2012 | - | $1.64 M(-35.7%) |
| Sep 2012 | - | $2.54 M(-27.2%) |
| Jun 2012 | - | $3.49 M(-5.9%) |
| Mar 2012 | - | $3.71 M(-24.4%) |
| Dec 2011 | $4.90 M | - |
| Dec 2011 | - | $4.90 M(+254.8%) |
| Sep 2011 | - | $1.38 M |
FAQ
- What is Can-Fite BioPharma annual total assets?
- What is the all time high annual total assets for Can-Fite BioPharma?
- What is Can-Fite BioPharma annual total assets year-on-year change?
- What is Can-Fite BioPharma quarterly total assets?
- What is the all time high quarterly total assets for Can-Fite BioPharma?
- What is Can-Fite BioPharma quarterly total assets year-on-year change?
What is Can-Fite BioPharma annual total assets?
The current annual total assets of CANF is $9.99 M
What is the all time high annual total assets for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual total assets is $20.25 M
What is Can-Fite BioPharma annual total assets year-on-year change?
Over the past year, CANF annual total assets has changed by +$706.00 K (+7.61%)
What is Can-Fite BioPharma quarterly total assets?
The current quarterly total assets of CANF is $5.92 M
What is the all time high quarterly total assets for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly total assets is $20.25 M
What is Can-Fite BioPharma quarterly total assets year-on-year change?
Over the past year, CANF quarterly total assets has changed by -$5.11 M (-46.32%)